Lv5
1010 积分 2023-07-08 加入
Non-systemic Intestine-Targeted Drugs
2天前
已完结
Trust Your Gut: Strategies and Tactics for Intestinally Restricted Drugs
2天前
已完结
Identification of 2,4-Diaminopyrimidine Derivatives as Novel Gut-Restricted Selective JAK1 Inhibitors for the Treatment of Inflammatory Bowel Disease
8天前
已完结
Identification of 2,4-Diaminopyrimidine Derivatives as Novel Gut-Restricted Selective JAK1 Inhibitors for the Treatment of Inflammatory Bowel Disease
16天前
已完结
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis
17天前
已完结
The Cell-Specific Effects of JAK1 Inhibitors in Ulcerative Colitis
17天前
已完结
JAK selectivity for inflammatory bowel disease treatment: does it clinically matter?
18天前
已完结
Arbutin Ameliorates Murine Colitis by Inhibiting JAK2 Signaling Pathway
18天前
已完结
The JAK2 inhibitor AG490 regulates the Treg/Th17 balance and alleviates DSS‐induced intestinal damage in IBD rats
18天前
已完结
INTESTINAL EPITHELIAL CELL-SPECIFIC DELETION OF JAK2 DISRUPTS GUT HOMEOSTASIS AND INCREASES INTESTINAL PERMEABILITY
18天前
已关闭
皖公网安备34019202002308
